Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 December 2003

The existence of an NAD-dependent pathway for retinoic acid formation from vitamin A (retinol) in rat esophagus and its inhibition by ethanoland histamine 2 (H2) receptor antagonists

Haruko Shiraishi-Yokoyama, Hirokazu Yokoyama, Michinaga Matsumoto, Hiromasa Ishii

Med Sci Monit 2003; 9(12): BR403-406 :: ID: 13415

Abstract

Background:Retinoic acid is essential for normal cell differentiation and proliferation and disturbance of its metabolism has been implicated in the pathogenesis of various disorders including malignancy. Retinoic acid has been demonstrated to be produced from retinol via a two step oxidation pathway in which alcohol dehydrogenase isozymes have roles. The aim of this study was to know whether the rat esophagus would have the pathway and whether the retinoic acid formation could be disturbed when alcohol dehydrogenase was hampered.Material/Methods:Rat esophageal cytosolic fraction, nicotinamide adenine dinucleotide, and all-trans retinol were incubated together and produced all-trans retinoic acid was detected by high performance liquid chromatography method.Results:Remarkable all-trans retinoic acid formation was observed only when nicotinamide adenine dinucleotide was in existence. The all-trans retinoic acid formation was hampered by addition of ethanol, another substrate of alcohol dehydrogenase, and some histamine 2 receptor antagonists, inhibitors of alcohol dehydrogenase.Conclusions:These results suggest that rat esophagus has an nicotinamide adenine dinucleotide-dependent all-trans retinoic acid formation pathway in which alcohol dehydrogenase is involved. We hypothesize that disturbance of the all-trans retinoic acid formation pathway by ethanol and histamine 2 receptors may cause various esophageal disorders including esophageal cancer seen in alcoholics and subjects taking histamine 2 receptors excessively.

Keywords: Alcohol Dehydrogenase - antagonists & inhibitors, Esophageal Neoplasms - etiology

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750